Skip to main content
Jane Titterington, MD, Cardiology, Kansas City, KS, The University of Kansas Hospital

JaneSibleyTitteringtonMDPhD

Cardiology Kansas City, KS

Heart Failure & Transplantation

Cardiology Fellow

Dr. Titterington is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Titterington's full profile

Already have an account?

Education & Training

  • Emory University School of Medicine
    Emory University School of MedicineFellowship, Advanced Heart Failure and Transplant Cardiology, 2017 - 2018
  • Emory University School of Medicine
    Emory University School of MedicineFellowship, Cardiovascular Disease, 2012 - 2017
  • Emory University School of Medicine
    Emory University School of MedicineResidency, Internal Medicine, 2010 - 2013
  • Tulane University School of Medicine
    Tulane University School of MedicineClass of 2010
  • Kansas State University
    Kansas State UniversityB.A., Microbiology major, Spanish minor, 1998 - 2002

Certifications & Licensure

  • KS State Medical License
    KS State Medical License 2018 - 2023
  • MO State Medical License
    MO State Medical License 2018 - 2023
  • GA State Medical License
    GA State Medical License Active through 2018

Awards, Honors, & Recognition

  • Haymaker Award Kansas State University Division of Biology, 2002
  • Phi Beta Kappa 2002
  • Research Award Kansas State University Center for Basic Cancer, 2001
  • Join now to see all

Publications & Presentations

PubMed

Abstracts/Posters

  • Growth hormone-releasing peptide-2 reduces oxidative stress in ApoE -/- mice but does not reduce atherosclerosis.
    Titterington JS, Sukhanov S, Vaughn CE, Delafontaine P, FASEB J, 1/1/2009
  • Insulin-like growth factor I downregulates lipoprotein lipase and suppresses atherosclerotic foam cell formation in vivo and in vitro.
    Sukhanov S. Vaughn CE, Higashi Y, Titterington JS, Delafontaine P, FASEB J, 1/1/2009
  • Chronic Left-Ventricular Dysfunction Increases Oxidative Stress in Skeletal Muscle: Potential Mechanism of Cardiac Cachexia.
    Semprun-Prieto L, Sukhanov S, Bhutto J, Titterington JS, Delafontaine P, FASEB J, 1/1/2009
  • Join now to see all

Lectures

  • Growth hormone-releasing peptide-2 reduces oxidative stress in ApoE -/- mice but does not reduce atherosclerosis. 
    Experimental Biology - 4/1/2009
  • Insulin-like growth factor I downregulates lipoprotein lipase and suppresses atherosclerotic foam cell formation in vivo and in vitro. 
    Experimental Biology - 4/1/2009
  • Chronic Left-Ventricular Dysfunction Increases Oxidative Stress in Skeletal Muscle: Potential Mechanism of Cardiac Cachexia. 
    Experimental Biology - 4/1/2009
  • Join now to see all

Press Mentions

  • Resveratrol-Mediated Expression of KLF15 in the Ischemic Myocardium Is Associated with an Improved Cardiac Phenotype
    Resveratrol-Mediated Expression of KLF15 in the Ischemic Myocardium Is Associated with an Improved Cardiac PhenotypeJanuary 7th, 2017

Hospital Affiliations